The CHMP gives a positive opinion to Eli Lilly's Jaypirca in patients with relapsed or refractory CLL in a post-BTK inhibitor setting.

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...

Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...

A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...

Class A shares of the Alger Spectra Fund outperformed the Russell 3000 Growth Index during the fourth quarter of 2024. Read ...